Both MPT64 alone and in combination with CLE (a fusion protein of early secretory antigenic target-6 [ESAT-6] and culture filtrate protein-10 [CFP-10]) significantly enhanced IFN-γ production in peripheral blood mononuclear cells (PBMCs) from TB patients, demonstrating high diagnostic sensitivity and specificity. This evidence concerns the gene IFNG and tuberculosis.